Navigation Links
Par Pharmaceutical Reports Fourth Quarter and Full Year 2008 Results
Date:3/2/2009

Reports Adjusted Q4 EPS of $0.21

WOODCLIFF LAKE, N.J., March 2 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today reported fourth quarter and full year 2008 results ended December 31, 2008.

Fourth Quarter and 2008 Results

For the fourth quarter ended December 31, 2008, Par reported total revenues of $161.3 million and a loss from continuing operations of $30.5 million, or $0.91 per share. This is compared with reported revenues of $155.1 million and income from continuing operations of $5.5 million, or $0.16 per diluted share, for the same period in 2007. For the year ended December 31, 2008, Par reported total revenues of $578.1 million and a loss from continuing operations of $45.9 million, or $1.38 per share. This is compared with reported revenues of $769.7 million and income from continuing operations of $51.1 million, or $1.47 per diluted share, for 2007.

Fourth quarter 2008 reported, or GAAP, loss from continuing operations also included the write-off of a restructuring charge of $15.4 million and other related costs of $3.8 million, $49.2 million in charges due to an unfavorable court decision and related legal fees, $5.3 million gain on non-core ANDA sales and the sale of other product rights, $4.9 million impairment charge related to various investments, and a $7.9 million gain related to early debt extinguishment. Adjusting for these items and other special items, income from continuing operations for the fourth quarter 2008 would have been $7.1 million, or $0.21 per diluted share. By comparison, fourth quarter 2007 results included a pre-tax gain of $3.1 million from Par's sale of its remaining investment in Optimer Pharmaceutical, Inc. common stock and $4.6 million of additional share-based compensation expense related to Par's employee stock option ten
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2015)... ... August 29, 2015 , ... Next weekend is Labor Day ... astronomically, officially ends on September 22nd this year). For IT security personnel, it should ... on which could prove far more costly than a simple headache. , Joe Caruso, ...
(Date:8/29/2015)... Aliso Viejo, CA (PRWEB) , ... August 29, 2015 , ... ... Cut Pro X . Each preset contains 15 seconds of unique footage that users ... presets that rise, fall, zoom, attract and more. Users can customize color, brightness, scale, ...
(Date:8/29/2015)... ... August 29, 2015 , ... People who ... disease (including emphysema), or asthma, are at higher risk from wildfire smoke especially ... heart failure or heart-rhythm problems (arrhythmia or irregular heartbeat) are also sensitive to ...
(Date:8/29/2015)... ... August 29, 2015 , ... ... the localized area with stretching, soft tissue manipulation. Platelet rich plasma injections also ... shown through research to improve treatment outcomes. This localized treatment seems to ...
(Date:8/29/2015)... ... ... The popular television program VOICES IN AMERICA, hosted by legendary star of the stage ... short segment to the subject of diabetes. Diabetes is a debilitating health condition that ... recent advancements in medical science may prove to be a significant breakthrough that sufferers ...
Breaking Medicine News(10 mins):Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 3Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 4Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2Health News:Heart Fit Clinic Sounds the Alarm on Forest Fire Smoke and Chronic Heart Disease in Calgary Area 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 3
... June 6. Even as asthma patients from different parts ... famed fish medicine, rationalists have stepped up their campaign ... group of rationalists, has again urged the Andhra Pradesh ... the 'drug' was based on 'superstition'. ,The Bathini ...
... the IOF World Congress on Osteoporosis, Toronto, cigarette smoking was ... new research reports//. ,Smoking has long been known ... new studies, two conducted in Sweden and one in China, ... In addition, the Chinese study demonstrates, for the first time, ...
... of immensely useful for the young doctors, to overcome the ... that even a little of sleep will lead to a ... enhance the doctors ability to care for their patients. ... Internal Medicine, researchers from the University of Chicago report that ...
... prematurely or with low birthweight are more likely to ... ,Premature or low birthweight babies are up to ... attention spans, suggests research published ahead of print in ... low attention span, and impulsive behaviour characterise the syndrome ...
... Representatives have passed a controversial bill on the 'national ... away //the power from local & state governments to ... that are likely to cause cancer, defects in birth, ... like those required in California and other states. The ...
... nabbed a Nigerian national and recovered 41 grams of ... secret information that Michael //Ofori Danagogo alias Mike, who ... would visit Motibagh area in south Delhi in the ... the trap and arrested him., ,He has been ...
Cached Medicine News:Health News:'Fishy' Medicine Stirs Controversy 2Health News:'Fishy' Medicine Stirs Controversy 3Health News:Smoking Increases Osteoporosis Risk 2Health News:Smoking Increases Osteoporosis Risk 3Health News:Small Naps are Beneficial for Doctors to Overcome Fatigue 2Health News:Small Naps are Beneficial for Doctors to Overcome Fatigue 3Health News:Association Asks People To Tell Their Senator To Vote against The "National Food Uniformity Act" 2
(Date:8/29/2015)... 29, 2015 La sofisticada ... los sistemas de imagen por Ultrasonidos   ofrece resultados ... examen rápidos y un flujo de trabajo   optimizado, ... el proceso de detección de Cardiopatías   ... hoy el lanzamiento europeo de HeartModel A.I ...
(Date:8/28/2015)... -- With the heroin epidemic in the United ... -based Lakeview Health drug and alcohol treatment center,s ... why fentanyl is causing a new wave of overdoses. ... potent than pharmaceutical grade heroin and often illegally purchased ... death skyrockets. "Fentanyl can be an important ...
(Date:8/28/2015)... N.C. , Aug. 28, 2015  Delays ... research projects can slow down the decision-making process, ... is, therefore, absolutely critical for biopharmaceutical companies to ... research approval process for quicker and more meaningful ... by Best Practices, LLC, nearly three-quarters of benchmarked ...
Breaking Medicine Technology:Philips presenta HeartModel A.I en el Congreso ESC 2015 2Philips presenta HeartModel A.I en el Congreso ESC 2015 3Philips presenta HeartModel A.I en el Congreso ESC 2015 4Philips presenta HeartModel A.I en el Congreso ESC 2015 5Lakeview Health's Dr. Philip Hemphill Explains Why Heroin Addicts Are Now Dying of Fentanyl Overdoses 2Expediting the Pharmaceutical Market Research Process for Faster Insights 2
... Hedgeye Risk Management Healthcare team, led by Tom Tobin, will host ... Demographics of Demand and Profits in Healthcare," where we will be ... 1994-2002 was so good, and why the next decade looks so ... for hip, knee, and spine device growth. -   ...
... Oct. 6 Pharmaceutical and biotech companies reach much ... partnerships between R&D and marketing, balancing therapeutic innovation with ... requires companies to break down the walls that have ... strengths of both talented medical researchers and skillful marketers. ...
Cached Medicine Technology:Aging of America: Demographics of Demand and Profits in Healthcare 2Creating Partnerships Across R&D and Marketing to Ensure a Successful Global Launch 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: